Academic detailing aids
NICE academic detailing aids (ADAs) are for use by experienced prescribing and medicines management personnel to support discussions with prescribers on key prescribing and medicines optimisation messages.
The principles that support the use of academic detailing to improve clinical decision-making, including reducing inappropriate prescribing as well as unnecessary healthcare expenditure, have been documented widely (Soumerai and Avorn 1990, National Audit Office 2007).
NICE has currently produced ADAs to support the implementation of NICE guidance and to support the QIPP medicines use and procurement workstream.
Support for the implementation of NICE guidance
These ADAs aim to support discussions with prescribers on one or more of the key priorities for implementation from a NICE guideline. Before using any ADA developed to support the implementation of NICE guidance, prescribers and medicines managers must familiarise themselves with the content of the guideline.
Support for the QIPP medicines use and procurement workstream
These ADAs aim to support discussions with prescribers on the key prescribing and medicines optimisation messages from ‘NPC Key Therapeutic Topics - medicines management options for local implementation'.
Before using one of these ADAs, users must familiarise themselves with the content of the relevant QIPP Key Slides and accompanying notes. Users are also advised to access the QIPP comparator data on this topic and familiarise themselves with local and national prescribing variations.
- Academic detailing aid: High dose inhaled corticosteroids (ICS) in asthma
- Academic detailing aid: Long-acting insulin analogues in type 2 diabetes mellitus
- Academic detailing aid: Low dose antipsychotics in people with dementia
- Academic detailing aid: Minocycline use in acne
- Academic detailing aid: NSAIDs
- Academic detailing aid: Three-day courses of trimethoprim for uncomplicated urinary tract infection (UTI)
These resources are not NICE guidance. Implementation tools should be used alongside the published guidance and do not supersede or replace the guidance itself.
What do you think?
Did the implementation tool you accessed today meet your requirements, and will it help you to put the NICE guidance into practice?
We value your opinion and are looking for ways to improve our tools. Please contact us with any feedback.
If you are experiencing problems accessing or using this tool, please email email@example.com.
This page was last updated: 27 September 2013